SCHEMBL20127615

SCHEMBL20127615

c1ccc2c(c1)cc(-c1ccc(-c3c4ccccc4c(-c4ccc5oc6c(ccc7c8ccccc8oc76)c5c4)c4ccccc34)cc1)c1ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 3/20 0.40
KDM4E B2RXH2 4/20 0.36
HPGD P15428 4/20 0.36
MAPT P10636 4/20 0.36
ALDH1A1 P00352 4/20 0.36
RAB9A P51151 3/20 0.36
NPC1 O15118 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CYP11B1 P15538 1/20 0.35
TSHR P16473 2/20 0.34
HSD17B10 Q99714 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
GPR84 Q9NQS5 2/20 0.34
GLA P06280 1/20 0.34
HTT P42858 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
AHR P35869 1/20 0.33
HSP90AA1 P07900 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10122387 0.93 ALOX5 (0.41) ALOX5KDM4EHPGDMAPTALDH1A1
SCHEMBL20127624 0.92 ALOX5 (0.44) ALOX5KDM4EHPGDMAPTALDH1A1
SCHEMBL24090166 0.92 KDM4E (0.42) ALOX5KDM4EHPGDMAPTALDH1A1
SCHEMBL10122410 0.91 ALOX5 (0.39) ALOX5KDM4EHPGDMAPTALDH1A1
SCHEMBL16067709 0.91 KDM4E (0.39) KDM4EHPGDMAPTALDH1A1RAB9A
SCHEMBL12578227 0.89 KDM4E (0.41) KDM4EHPGDMAPTALDH1A1RAB9A
SCHEMBL10122427 0.89 ALOX5 (0.40) ALOX5KDM4EHPGDMAPTALDH1A1
SCHEMBL25052527 0.88 ALOX5 (0.46) ALOX5KDM4EHPGDMAPTALDH1A1
SCHEMBL15195388 0.88 KDM4E (0.41) KDM4EHPGDMAPTALDH1A1RAB9A
SCHEMBL12577739 0.88 MAPT (0.41) ALOX5KDM4EHPGDMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 ALOX5 4115/4885KDM4E 4144/4885HPGD 4205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.